1. Abola, E.E., Berstein, F.C., Bryant, S.H., Koetzle, T.F., Weng, J., 1987. Protein data bank, crystallographic databases—information content, software systems, scientific applications. In: Allen, F.H., Berjerhoff, G., Sievers, R. (Eds.), Data Commission of the International Union of Crystallography. Bonn, pp. 171–200.
2. Anonymous, 2001. 50 top selling drugs ranked by worldwide sales for 2000, Patent scan—a monthly proactive patents bulletin for pharmaceutical industry. Med. Ad News 2 (12).
3. Characterization of polymorphism of gepirone hydrochloride;Behme;J. Pharm. Sci.,1985
4. Spectral methods for the characterization of polymorphs and solvates;Brittain;J. Pharm. Sci.,1997
5. Brittain, H., Fiese, E., 1999. Effects of pharmaceutical processing on drug polymorphs and solvates. In: Swarbrick, J. (Ed.), Polymorphism in Pharmaceutical Solids. Marcel Dekker, New York, pp. 331–365.